This article will be permanently flagged as inappropriate and made unaccessible to everyone. Are you certain this article is inappropriate? Excessive Violence Sexual Content Political / Social
Email Address:
Article Id: WHEBN0005210934 Reproduction Date:
Bitolterol mesylate (Tornalate) is a β2-adrenergic receptor agonist used for the relief of bronchospasm in conditions such as asthma[1][2] and COPD.[3][4][5] In these disorders there is a narrowing of the airways (bronchi and their ramifications) that carry air to the lungs. Muscle spasm and inflammation within the bronchi get worse this narrowing. Bitolterol relaxes the smooth muscles present continuously around the bronchi and bronchioles facilitating the flow of air through them.
Bitolterol has a rapid onset of action (2–5 minutes) and may last up to 6–8 hours.[6] The drug, alone or in co-administration with theophylline, doesn't show cardiotoxic effect.[7]
The USA Food and Drug Administration (FDA) approved bitolterol in December 1984. The drug was withdrawn from the market by Élan Pharmaceuticals in 2001.
Amphetamine, Methylphenidate, Cocaine, Ethanol, Norepinephrine
Amphetamine, Methamphetamine, Dopamine, Sympathetic nervous system, Epinephrine
Methamphetamine, Addiction, Norepinephrine, Gene expression, PubChem
Diamond, Graphite, Solar system, Coal, /anolanthanide Chemistry
Methamphetamine, Norepinephrine, Amphetamine, Xenon, Indacaterol
Methamphetamine, Oxygen, Norepinephrine, Amphetamine, Epinephrine
Methamphetamine, Amphetamine, Norepinephrine, Asthma, GlaxoSmithKline
Abediterol, Alifedrine, Amibegron, Arbutamine, Arformoterol
Ergoline, Serotonin, Lysergic acid diethylamide, 5-Methoxytryptamine, Substituted tryptamine